nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—POLD1—respiratory system—chronic obstructive pulmonary disease	0.0182	0.0603	CbGeAlD
Gemcitabine—SLC28A3—respiratory system—chronic obstructive pulmonary disease	0.0167	0.0553	CbGeAlD
Gemcitabine—CMPK1—respiratory system—chronic obstructive pulmonary disease	0.0145	0.0481	CbGeAlD
Gemcitabine—CMPK1—connective tissue—chronic obstructive pulmonary disease	0.0128	0.0423	CbGeAlD
Gemcitabine—SLC28A3—trachea—chronic obstructive pulmonary disease	0.0123	0.0409	CbGeAlD
Gemcitabine—CMPK1—bronchus—chronic obstructive pulmonary disease	0.012	0.0396	CbGeAlD
Gemcitabine—CMPK1—smooth muscle tissue—chronic obstructive pulmonary disease	0.0117	0.0387	CbGeAlD
Gemcitabine—RRM2—respiratory system—chronic obstructive pulmonary disease	0.0112	0.0371	CbGeAlD
Gemcitabine—POLE—trachea—chronic obstructive pulmonary disease	0.0101	0.0333	CbGeAlD
Gemcitabine—POLD1—lung—chronic obstructive pulmonary disease	0.00967	0.032	CbGeAlD
Gemcitabine—RRM1—respiratory system—chronic obstructive pulmonary disease	0.00931	0.0308	CbGeAlD
Gemcitabine—RRM2—bronchus—chronic obstructive pulmonary disease	0.00922	0.0305	CbGeAlD
Gemcitabine—SLC28A3—lung—chronic obstructive pulmonary disease	0.00886	0.0294	CbGeAlD
Gemcitabine—TYMS—respiratory system—chronic obstructive pulmonary disease	0.00844	0.028	CbGeAlD
Gemcitabine—CMPK1—lung—chronic obstructive pulmonary disease	0.00771	0.0255	CbGeAlD
Gemcitabine—RRM1—bronchus—chronic obstructive pulmonary disease	0.00766	0.0254	CbGeAlD
Gemcitabine—SLC29A1—respiratory system—chronic obstructive pulmonary disease	0.00757	0.0251	CbGeAlD
Gemcitabine—RRM1—smooth muscle tissue—chronic obstructive pulmonary disease	0.0075	0.0248	CbGeAlD
Gemcitabine—TYMS—connective tissue—chronic obstructive pulmonary disease	0.00743	0.0246	CbGeAlD
Gemcitabine—POLE—lung—chronic obstructive pulmonary disease	0.00723	0.0239	CbGeAlD
Gemcitabine—TYMS—bronchus—chronic obstructive pulmonary disease	0.00695	0.023	CbGeAlD
Gemcitabine—TYMS—smooth muscle tissue—chronic obstructive pulmonary disease	0.0068	0.0225	CbGeAlD
Gemcitabine—SLC29A1—connective tissue—chronic obstructive pulmonary disease	0.00666	0.0221	CbGeAlD
Gemcitabine—SLC29A1—bronchus—chronic obstructive pulmonary disease	0.00623	0.0206	CbGeAlD
Gemcitabine—POLA1—lung—chronic obstructive pulmonary disease	0.00623	0.0206	CbGeAlD
Gemcitabine—DCK—bronchus—chronic obstructive pulmonary disease	0.00595	0.0197	CbGeAlD
Gemcitabine—RRM2—lung—chronic obstructive pulmonary disease	0.00595	0.0197	CbGeAlD
Gemcitabine—ABCC10—bronchus—chronic obstructive pulmonary disease	0.00567	0.0188	CbGeAlD
Gemcitabine—SLC29A1—trachea—chronic obstructive pulmonary disease	0.00559	0.0185	CbGeAlD
Gemcitabine—DCK—trachea—chronic obstructive pulmonary disease	0.00534	0.0177	CbGeAlD
Gemcitabine—ABCC10—trachea—chronic obstructive pulmonary disease	0.00509	0.0169	CbGeAlD
Gemcitabine—RRM1—lung—chronic obstructive pulmonary disease	0.00494	0.0164	CbGeAlD
Gemcitabine—TYMS—lung—chronic obstructive pulmonary disease	0.00448	0.0148	CbGeAlD
Gemcitabine—SLC29A1—lung—chronic obstructive pulmonary disease	0.00402	0.0133	CbGeAlD
Gemcitabine—DCK—lung—chronic obstructive pulmonary disease	0.00384	0.0127	CbGeAlD
Gemcitabine—ABCC10—lung—chronic obstructive pulmonary disease	0.00366	0.0121	CbGeAlD
Gemcitabine—POLD1—Danazol—Prednisone—chronic obstructive pulmonary disease	0.00289	0.194	CbGdCrCtD
Gemcitabine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00199	0.00659	CbGeAlD
Gemcitabine—SLC28A1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.00188	0.0311	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00174	0.0288	CbGpPWpGaD
Gemcitabine—TYMS—Trans-sulfuration and one carbon metabolism—GCLC—chronic obstructive pulmonary disease	0.00173	0.0287	CbGpPWpGaD
Gemcitabine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00262	CcSEcCtD
Gemcitabine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00261	CcSEcCtD
Gemcitabine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00163	0.00261	CcSEcCtD
Gemcitabine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00162	0.00261	CcSEcCtD
Gemcitabine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.0026	CcSEcCtD
Gemcitabine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00162	0.00259	CcSEcCtD
Gemcitabine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00259	CcSEcCtD
Gemcitabine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00161	0.00259	CcSEcCtD
Gemcitabine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00161	0.00258	CcSEcCtD
Gemcitabine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00159	0.00255	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00159	0.00255	CcSEcCtD
Gemcitabine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00253	CcSEcCtD
Gemcitabine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00158	0.00253	CcSEcCtD
Gemcitabine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00252	CcSEcCtD
Gemcitabine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00252	CcSEcCtD
Gemcitabine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00251	CcSEcCtD
Gemcitabine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00156	0.0025	CcSEcCtD
Gemcitabine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.0025	CcSEcCtD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00155	0.0257	CbGpPWpGaD
Gemcitabine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00249	CcSEcCtD
Gemcitabine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00249	CcSEcCtD
Gemcitabine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.00153	0.0254	CbGpPWpGaD
Gemcitabine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00153	0.00246	CcSEcCtD
Gemcitabine—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00245	CcSEcCtD
Gemcitabine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00151	0.00242	CcSEcCtD
Gemcitabine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.0015	0.0024	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00149	0.00239	CcSEcCtD
Gemcitabine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00239	CcSEcCtD
Gemcitabine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00239	CcSEcCtD
Gemcitabine—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00148	0.00238	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00237	CcSEcCtD
Gemcitabine—ABCB1—trachea—chronic obstructive pulmonary disease	0.00147	0.00487	CbGeAlD
Gemcitabine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00147	0.00236	CcSEcCtD
Gemcitabine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00235	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00146	0.0242	CbGpPWpGaD
Gemcitabine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00146	0.00234	CcSEcCtD
Gemcitabine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00232	CcSEcCtD
Gemcitabine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00232	CcSEcCtD
Gemcitabine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.00142	0.0236	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00142	0.0235	CbGpPWpGaD
Gemcitabine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00226	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00225	CcSEcCtD
Gemcitabine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00225	CcSEcCtD
Gemcitabine—Cough—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00225	CcSEcCtD
Gemcitabine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00139	0.00223	CcSEcCtD
Gemcitabine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00222	CcSEcCtD
Gemcitabine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00222	CcSEcCtD
Gemcitabine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00221	CcSEcCtD
Gemcitabine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00137	0.0022	CcSEcCtD
Gemcitabine—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.00137	0.0022	CcSEcCtD
Gemcitabine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00219	CcSEcCtD
Gemcitabine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00219	CcSEcCtD
Gemcitabine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00219	CcSEcCtD
Gemcitabine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00219	CcSEcCtD
Gemcitabine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00219	CcSEcCtD
Gemcitabine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00219	CcSEcCtD
Gemcitabine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00219	CcSEcCtD
Gemcitabine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00218	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00218	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00218	CcSEcCtD
Gemcitabine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00218	CcSEcCtD
Gemcitabine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00217	CcSEcCtD
Gemcitabine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00217	CcSEcCtD
Gemcitabine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00215	CcSEcCtD
Gemcitabine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00215	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00213	CcSEcCtD
Gemcitabine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00212	CcSEcCtD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00132	0.0219	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.0021	CcSEcCtD
Gemcitabine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.0021	CcSEcCtD
Gemcitabine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00131	0.0021	CcSEcCtD
Gemcitabine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00131	0.0021	CcSEcCtD
Gemcitabine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.0021	CcSEcCtD
Gemcitabine—Infection—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00209	CcSEcCtD
Gemcitabine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00209	CcSEcCtD
Gemcitabine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00207	CcSEcCtD
Gemcitabine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00207	CcSEcCtD
Gemcitabine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00207	CcSEcCtD
Gemcitabine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00206	CcSEcCtD
Gemcitabine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00206	CcSEcCtD
Gemcitabine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00206	CcSEcCtD
Gemcitabine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00206	CcSEcCtD
Gemcitabine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00206	CcSEcCtD
Gemcitabine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00205	CcSEcCtD
Gemcitabine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00127	0.00205	CcSEcCtD
Gemcitabine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00204	CcSEcCtD
Gemcitabine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00204	CcSEcCtD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00126	0.021	CbGpPWpGaD
Gemcitabine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00202	CcSEcCtD
Gemcitabine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00202	CcSEcCtD
Gemcitabine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00201	CcSEcCtD
Gemcitabine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00125	0.002	CcSEcCtD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00124	0.0206	CbGpPWpGaD
Gemcitabine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00198	CcSEcCtD
Gemcitabine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00198	CcSEcCtD
Gemcitabine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00197	CcSEcCtD
Gemcitabine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00196	CcSEcCtD
Gemcitabine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00196	CcSEcCtD
Gemcitabine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00195	CcSEcCtD
Gemcitabine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00195	CcSEcCtD
Gemcitabine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00193	CcSEcCtD
Gemcitabine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00192	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00191	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00191	CcSEcCtD
Gemcitabine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00118	0.0019	CcSEcCtD
Gemcitabine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.0019	CcSEcCtD
Gemcitabine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00189	CcSEcCtD
Gemcitabine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00118	0.00189	CcSEcCtD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00118	0.0195	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00188	CcSEcCtD
Gemcitabine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00187	CcSEcCtD
Gemcitabine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00187	CcSEcCtD
Gemcitabine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00187	CcSEcCtD
Gemcitabine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00187	CcSEcCtD
Gemcitabine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00186	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00186	CcSEcCtD
Gemcitabine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00185	CcSEcCtD
Gemcitabine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00185	CcSEcCtD
Gemcitabine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00184	CcSEcCtD
Gemcitabine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00183	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00181	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00181	CcSEcCtD
Gemcitabine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00181	CcSEcCtD
Gemcitabine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00181	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00181	CcSEcCtD
Gemcitabine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.0018	CcSEcCtD
Gemcitabine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00112	0.0018	CcSEcCtD
Gemcitabine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.0018	CcSEcCtD
Gemcitabine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00112	0.0018	CcSEcCtD
Gemcitabine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00179	CcSEcCtD
Gemcitabine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00178	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00178	CcSEcCtD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00111	0.0183	CbGpPWpGaD
Gemcitabine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00177	CcSEcCtD
Gemcitabine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00177	CcSEcCtD
Gemcitabine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00176	CcSEcCtD
Gemcitabine—Pain—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00176	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.0011	0.00176	CcSEcCtD
Gemcitabine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00176	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00175	CcSEcCtD
Gemcitabine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00175	CcSEcCtD
Gemcitabine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00174	CcSEcCtD
Gemcitabine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00174	CcSEcCtD
Gemcitabine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00173	CcSEcCtD
Gemcitabine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00173	CcSEcCtD
Gemcitabine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00173	CcSEcCtD
Gemcitabine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00173	CcSEcCtD
Gemcitabine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00172	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00171	CcSEcCtD
Gemcitabine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00171	CcSEcCtD
Gemcitabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.00106	0.0176	CbGpPWpGaD
Gemcitabine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.0017	CcSEcCtD
Gemcitabine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.0017	CcSEcCtD
Gemcitabine—ABCB1—lung—chronic obstructive pulmonary disease	0.00106	0.0035	CbGeAlD
Gemcitabine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00166	CcSEcCtD
Gemcitabine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00166	CcSEcCtD
Gemcitabine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00166	CcSEcCtD
Gemcitabine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00164	CcSEcCtD
Gemcitabine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00164	CcSEcCtD
Gemcitabine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00164	CcSEcCtD
Gemcitabine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00164	CcSEcCtD
Gemcitabine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00163	CcSEcCtD
Gemcitabine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00163	CcSEcCtD
Gemcitabine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00162	CcSEcCtD
Gemcitabine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.001	0.00161	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.001	0.0673	CbGdCrCtD
Gemcitabine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000998	0.0016	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000984	0.0163	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.000977	0.0657	CbGdCrCtD
Gemcitabine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000977	0.00157	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.000972	0.0653	CbGdCrCtD
Gemcitabine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000963	0.00155	CcSEcCtD
Gemcitabine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000954	0.00153	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.000949	0.0638	CbGdCrCtD
Gemcitabine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000939	0.00151	CcSEcCtD
Gemcitabine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000939	0.00151	CcSEcCtD
Gemcitabine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000926	0.00149	CcSEcCtD
Gemcitabine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000926	0.00149	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000924	0.00148	CcSEcCtD
Gemcitabine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00092	0.00148	CcSEcCtD
Gemcitabine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000907	0.00146	CcSEcCtD
Gemcitabine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000896	0.00144	CcSEcCtD
Gemcitabine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000896	0.00144	CcSEcCtD
Gemcitabine—CDA—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000893	0.0148	CbGpPWpGaD
Gemcitabine—RRM1—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000892	0.0148	CbGpPWpGaD
Gemcitabine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000891	0.00143	CcSEcCtD
Gemcitabine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000887	0.00142	CcSEcCtD
Gemcitabine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000877	0.00141	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000877	0.0145	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000877	0.0145	CbGpPWpGaD
Gemcitabine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000874	0.0014	CcSEcCtD
Gemcitabine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000869	0.00139	CcSEcCtD
Gemcitabine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000847	0.00136	CcSEcCtD
Gemcitabine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000846	0.00136	CcSEcCtD
Gemcitabine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000832	0.00134	CcSEcCtD
Gemcitabine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000832	0.00134	CcSEcCtD
Gemcitabine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000825	0.00133	CcSEcCtD
Gemcitabine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000825	0.00133	CcSEcCtD
Gemcitabine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000825	0.00132	CcSEcCtD
Gemcitabine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000825	0.00132	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000824	0.0137	CbGpPWpGaD
Gemcitabine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00082	0.00132	CcSEcCtD
Gemcitabine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00082	0.00132	CcSEcCtD
Gemcitabine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000817	0.00131	CcSEcCtD
Gemcitabine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000815	0.00131	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.000813	0.0546	CbGdCrCtD
Gemcitabine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000808	0.0013	CcSEcCtD
Gemcitabine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000808	0.0013	CcSEcCtD
Gemcitabine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000806	0.00129	CcSEcCtD
Gemcitabine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000803	0.00129	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.000802	0.0539	CbGdCrCtD
Gemcitabine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000796	0.00128	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.000794	0.0534	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.000793	0.0533	CbGdCrCtD
Gemcitabine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000792	0.00127	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000792	0.00127	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000789	0.0131	CbGpPWpGaD
Gemcitabine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000786	0.00126	CcSEcCtD
Gemcitabine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000783	0.00126	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.000783	0.0526	CbGdCrCtD
Gemcitabine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000779	0.00125	CcSEcCtD
Gemcitabine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000779	0.00125	CcSEcCtD
Gemcitabine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000778	0.00125	CcSEcCtD
Gemcitabine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000778	0.00125	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.000775	0.0521	CbGdCrCtD
Gemcitabine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000774	0.00124	CcSEcCtD
Gemcitabine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000762	0.00122	CcSEcCtD
Gemcitabine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00075	0.0012	CcSEcCtD
Gemcitabine—RRM2—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000735	0.0122	CbGpPWpGaD
Gemcitabine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000734	0.00118	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.000732	0.0492	CbGdCrCtD
Gemcitabine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000731	0.00117	CcSEcCtD
Gemcitabine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000729	0.00117	CcSEcCtD
Gemcitabine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000725	0.00116	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.000714	0.048	CbGdCrCtD
Gemcitabine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000713	0.00114	CcSEcCtD
Gemcitabine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000709	0.00114	CcSEcCtD
Gemcitabine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000709	0.00114	CcSEcCtD
Gemcitabine—RRM1—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.00069	0.0114	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000685	0.0011	CcSEcCtD
Gemcitabine—RRM1—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000677	0.0112	CbGpPWpGaD
Gemcitabine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000658	0.00106	CcSEcCtD
Gemcitabine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000655	0.00105	CcSEcCtD
Gemcitabine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000648	0.00104	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.000642	0.0431	CbGdCrCtD
Gemcitabine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000641	0.00103	CcSEcCtD
Gemcitabine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000641	0.00103	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000637	0.00102	CcSEcCtD
Gemcitabine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000631	0.00101	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.000626	0.0421	CbGdCrCtD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000619	0.0103	CbGpPWpGaD
Gemcitabine—TYMS—Danazol—Prednisone—chronic obstructive pulmonary disease	0.000615	0.0413	CbGdCrCtD
Gemcitabine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000606	0.000973	CcSEcCtD
Gemcitabine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000586	0.00094	CcSEcCtD
Gemcitabine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000584	0.000938	CcSEcCtD
Gemcitabine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000583	0.000937	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000581	0.00963	CbGpPWpGaD
Gemcitabine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000569	0.000914	CcSEcCtD
Gemcitabine—RRM2—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000568	0.00941	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GC—chronic obstructive pulmonary disease	0.000565	0.00936	CbGpPWpGaD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000557	0.00923	CbGpPWpGaD
Gemcitabine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000545	0.000875	CcSEcCtD
Gemcitabine—CDA—Metabolism—APIP—chronic obstructive pulmonary disease	0.000542	0.00898	CbGpPWpGaD
Gemcitabine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000537	0.000863	CcSEcCtD
Gemcitabine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000537	0.000863	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000534	0.000857	CcSEcCtD
Gemcitabine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000531	0.000852	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000525	0.00871	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000515	0.000827	CcSEcCtD
Gemcitabine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000515	0.000827	CcSEcCtD
Gemcitabine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000512	0.000822	CcSEcCtD
Gemcitabine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000505	0.000811	CcSEcCtD
Gemcitabine—POLA1—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000502	0.00832	CbGpPWpGaD
Gemcitabine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.0005	0.000803	CcSEcCtD
Gemcitabine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000498	0.0008	CcSEcCtD
Gemcitabine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000491	0.000788	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000481	0.00798	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000469	0.000754	CcSEcCtD
Gemcitabine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000466	0.000748	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000463	0.000743	CcSEcCtD
Gemcitabine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000448	0.000719	CcSEcCtD
Gemcitabine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000447	0.000718	CcSEcCtD
Gemcitabine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000447	0.000717	CcSEcCtD
Gemcitabine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000444	0.000713	CcSEcCtD
Gemcitabine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000444	0.000713	CcSEcCtD
Gemcitabine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000441	0.000707	CcSEcCtD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000428	0.00709	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000424	0.000682	CcSEcCtD
Gemcitabine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.000676	CcSEcCtD
Gemcitabine—RRM1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000411	0.0068	CbGpPWpGaD
Gemcitabine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000407	0.000654	CcSEcCtD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000403	0.00669	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000389	0.00644	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000372	0.00617	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00037	0.00613	CbGpPWpGaD
Gemcitabine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00037	0.000593	CcSEcCtD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000365	0.00605	CbGpPWpGaD
Gemcitabine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000364	0.000585	CcSEcCtD
Gemcitabine—CDA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000359	0.00595	CbGpPWpGaD
Gemcitabine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000352	0.000566	CcSEcCtD
Gemcitabine—CDA—Metabolism—GC—chronic obstructive pulmonary disease	0.000349	0.00579	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000341	0.00566	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.00034	0.00563	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000338	0.00561	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000338	0.0056	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000336	0.00557	CbGpPWpGaD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000329	0.00545	CbGpPWpGaD
Gemcitabine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000328	0.000526	CcSEcCtD
Gemcitabine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000325	0.000522	CcSEcCtD
Gemcitabine—CDA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000325	0.00538	CbGpPWpGaD
Gemcitabine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000521	CcSEcCtD
Gemcitabine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000518	CcSEcCtD
Gemcitabine—DCK—Metabolism—APIP—chronic obstructive pulmonary disease	0.000316	0.00524	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000312	0.00516	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000309	0.00512	CbGpPWpGaD
Gemcitabine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000306	0.000491	CcSEcCtD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000306	0.00507	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000305	0.00506	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—chronic obstructive pulmonary disease	0.0003	0.00497	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000278	0.00461	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000278	0.00461	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000272	0.00451	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000267	0.00442	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GC—chronic obstructive pulmonary disease	0.000265	0.00438	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000259	0.00429	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000257	0.00425	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000257	0.00425	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000246	0.00408	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000246	0.00408	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000246	0.00407	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000244	0.00404	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000243	0.00403	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.00024	0.00397	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000228	0.00378	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000224	0.00371	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000223	0.00369	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APIP—chronic obstructive pulmonary disease	0.000222	0.00367	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.00022	0.00364	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GC—chronic obstructive pulmonary disease	0.000218	0.00361	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GC—chronic obstructive pulmonary disease	0.000217	0.00359	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000214	0.00355	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000211	0.0035	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000211	0.0035	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000209	0.00347	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000207	0.00343	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000205	0.0034	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GC—chronic obstructive pulmonary disease	0.000204	0.00337	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000203	0.00336	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000202	0.00334	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000201	0.00334	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000198	0.00328	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000197	0.00326	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000197	0.00326	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000195	0.00323	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000193	0.0032	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000191	0.00316	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000189	0.00314	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000189	0.00312	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000188	0.00312	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.00309	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000179	0.00297	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000176	0.00291	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000172	0.00285	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000168	0.00279	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000167	0.00277	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000167	0.00277	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000166	0.00275	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000166	0.00274	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00016	0.00264	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000159	0.00263	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000159	0.00263	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000155	0.00257	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000148	0.00245	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000147	0.00243	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000146	0.00242	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000145	0.0024	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000143	0.00237	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GC—chronic obstructive pulmonary disease	0.000143	0.00237	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000133	0.0022	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000132	0.00219	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00013	0.00216	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00013	0.00216	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000127	0.0021	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000125	0.00206	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000124	0.00205	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000121	0.00201	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000121	0.00201	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.00199	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000119	0.00197	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000119	0.00197	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000118	0.00196	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000118	0.00195	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000117	0.00194	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000116	0.00192	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00191	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000114	0.00188	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000111	0.00185	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000111	0.00184	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00011	0.00182	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000109	0.0018	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000107	0.00178	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000107	0.00177	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000107	0.00177	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000106	0.00176	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000102	0.00168	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CTGF—chronic obstructive pulmonary disease	0.0001	0.00166	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.0001	0.00166	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.89e-05	0.00164	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.88e-05	0.00164	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.83e-05	0.00163	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.36e-05	0.00155	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.24e-05	0.00153	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.21e-05	0.00153	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	9.13e-05	0.00151	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.96e-05	0.00149	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	8.76e-05	0.00145	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.73e-05	0.00145	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	8.61e-05	0.00143	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.57e-05	0.00142	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.25e-05	0.00137	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.2e-05	0.00136	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.14e-05	0.00135	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.09e-05	0.00134	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	7.88e-05	0.00131	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ALB—chronic obstructive pulmonary disease	7.83e-05	0.0013	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.8e-05	0.00129	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GCLC—chronic obstructive pulmonary disease	7.71e-05	0.00128	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.71e-05	0.00128	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.6e-05	0.00126	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.58e-05	0.00126	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.54e-05	0.00125	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NOS3—chronic obstructive pulmonary disease	7.49e-05	0.00124	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	7.42e-05	0.00123	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.19e-05	0.00119	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.14e-05	0.00118	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.09e-05	0.00117	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CTGF—chronic obstructive pulmonary disease	7.04e-05	0.00117	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	6.84e-05	0.00113	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.81e-05	0.00113	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.72e-05	0.00111	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.48e-05	0.00107	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.36e-05	0.00105	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ALB—chronic obstructive pulmonary disease	5.93e-05	0.000983	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—chronic obstructive pulmonary disease	5.92e-05	0.000981	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—chronic obstructive pulmonary disease	5.89e-05	0.000975	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—chronic obstructive pulmonary disease	5.68e-05	0.000942	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.68e-05	0.00094	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.41e-05	0.000896	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.33e-05	0.000884	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.97e-05	0.000823	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALB—chronic obstructive pulmonary disease	4.89e-05	0.00081	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALB—chronic obstructive pulmonary disease	4.86e-05	0.000805	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.71e-05	0.00078	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.67e-05	0.000774	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.64e-05	0.00077	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALB—chronic obstructive pulmonary disease	4.57e-05	0.000757	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.53e-05	0.00075	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.41e-05	0.00073	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NOS3—chronic obstructive pulmonary disease	4.37e-05	0.000724	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.1e-05	0.000679	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—chronic obstructive pulmonary disease	4.05e-05	0.000671	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—chronic obstructive pulmonary disease	3.88e-05	0.000643	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.66e-05	0.000607	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.51e-05	0.000582	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.36e-05	0.000557	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.29e-05	0.000546	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALB—chronic obstructive pulmonary disease	3.2e-05	0.00053	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.14e-05	0.00052	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NOS3—chronic obstructive pulmonary disease	3.06e-05	0.000507	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.77e-05	0.000458	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.41e-05	0.000399	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.38e-05	0.000394	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.17e-05	0.00036	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.11e-05	0.000349	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2e-05	0.000331	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.67e-05	0.000276	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.65e-05	0.000273	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.53e-05	0.000254	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.45e-05	0.000241	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	9.88e-06	0.000164	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.45e-06	0.000157	CbGpPWpGaD
